Transition of Brighton Collaboration

May 21, 2019

Dear Partners and Visitors

As announced on the 21st of May 2019, the Brighton Collaboration will be dissolved as a Partnership under Swiss law and reconstituted as a programme of the Task Force for Global Health (TFGH; www.taskforce.org).

The Swiss Brighton Collaboration Foundation, it’s Foundation Board and Management Team remain available to ensure access to the Academy until the new programme is settled in at TFGH.

Click here to see the full BC Communication.

More News

Lessons Learned from Vaccine Safety Surveillance Efforts

September 3, 2024

Dr. Punnee Pitisuttithum: Engaging community in active vaccine safety surveillance

July 31, 2024

Request for Review: Vaccine Safety Template – IDT Bio Manuscript

July 22, 2024

Request for Review: Vaccine Safety Template for Clover COVID-19 recombinant protein vaccine

July 2, 2024

Ensuring the safety of dengue vaccines: Alejandro Cravioto brings international expertise to the Pan-American Advisory Committee on Vaccine Safety

May 30, 2024

Dr. Eileen Farnon joins Brighton Collaboration as Research Director

March 22, 2024

More NEWS

September 3, 2024

Lessons Learned from Vaccine Safety Surveillance Efforts

Much has been learned about the need for vaccine safety surveillance through COVAX and other recent collaborative efforts. Here, w...

July 31, 2024September 9, 2024

Dr. Punnee Pitisuttithum: Engaging community in active vaccine safety surveillance

A member of both Brighton Collaboration and the Safety Platform for Emergency vACcines project’s Meta-DSMB, Dr. Punnee Pitis...

July 22, 2024July 22, 2024

Request for Review: Vaccine Safety Template – IDT Bio Manuscript

The proposed IDT Modified Vaccinia virus Ankara viral vector vaccine manuscript is ready for peer review. The Brighton Collaborati...

Email:
bc-coordinator@taskforce.org

Address:
The Task Force for Global Health,
330 W. Ponce de Leon Ave.
Decatur, GA 30030

© Brighton Collaboration 2023. All rights reserved.